Literature DB >> 15640327

Cardiopulmonary effects of iloprost in experimental acute lung injury.

R Dembinski1, W Brackhahn, D Henzler, A Rott, R Bensberg, R Kuhlen, R Rossaint.   

Abstract

Iloprost, a prostacyclin analogue with a prolonged plasma half-life has beneficial effects in chronic pulmonary hypertension, whereas the effects in acute lung injury (ALI) are unknown. The present study was performed to evaluate the cardiopulmonary effects of iloprost in experimental ALI. ALI was induced in 18 pigs by repeated lung lavage. Animals were randomised to controls, i.v. or inhaled iloprost for 15 min. Haemodynamics, gas exchange and ventilation-perfusion distribution were measured at the end of iloprost application and after 1 and 2 h. As a short-term effect, both i.v. and inhaled iloprost significantly decreased pulmonary artery pressure without major effects on gas exchange or systemic haemodynamics. After 1 and 2 h, a reduction of pulmonary hypertension was no longer present. As a long-term effect, inhaled, but not i.v., iloprost decreased pulmonary shunt and significantly improved gas exchange after 1 and 2 h. In conclusion, the single application of iloprost revealed short-term pulmonary vasodilation without other major cardiopulmonary effects. However, inhaled iloprost improved gas exchange due to a decrease of pulmonary shunt as a long-term effect, possibly as a result of a reduction of lung oedema formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15640327     DOI: 10.1183/09031936.04.10085504

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

1.  Iloprost attenuates hyperoxia-mediated impairment of lung development in newborn mice.

Authors:  Nelida Olave; Charitharth Vivek Lal; Brian Halloran; Vineet Bhandari; Namasivayam Ambalavanan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-06-28       Impact factor: 5.464

2.  Lung endothelial barrier protection by iloprost in the 2-hit models of ventilator-induced lung injury (VILI) involves inhibition of Rho signaling.

Authors:  Anna A Birukova; Panfeng Fu; Junjie Xing; Ivan Cokic; Konstantin G Birukov
Journal:  Transl Res       Date:  2010-01       Impact factor: 7.012

3.  Rap1 mediates protective effects of iloprost against ventilator-induced lung injury.

Authors:  Anna A Birukova; Panfeng Fu; Junjie Xing; Konstantin G Birukov
Journal:  J Appl Physiol (1985)       Date:  2009-10-22

4.  Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury.

Authors:  Anna A Birukova; Tinghuai Wu; Yufeng Tian; Angelo Meliton; Nicolene Sarich; Xinyong Tian; Alan Leff; Konstantin G Birukov
Journal:  Eur Respir J       Date:  2012-07-12       Impact factor: 16.671

Review 5.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

6.  Effects of intraoperative inhaled iloprost on primary graft dysfunction after lung transplantation: A retrospective single center study.

Authors:  Su Hyun Lee; Jin Gu Lee; Chang Yeong Lee; Namo Kim; Min-Yung Chang; Young-Chul You; Hyun Joo Kim; Hyo Chae Paik; Young Jun Oh
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

7.  Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study.

Authors:  Helene Haeberle; Stefanie Prohaska; Peter Martus; Andreas Straub; Alexander Zarbock; Gernot Marx; Manola Zago; Martin Giera; Michael Koeppen; Peter Rosenberger
Journal:  Trials       Date:  2020-03-04       Impact factor: 2.279

8.  Effects of inhaled iloprost on right ventricular contractility, right ventriculo-vascular coupling and ventricular interdependence: a randomized placebo-controlled trial in an experimental model of acute pulmonary hypertension.

Authors:  Steffen Rex; Carlo Missant; Piet Claus; Wolfgang Buhre; Patrick F Wouters
Journal:  Crit Care       Date:  2008-09-10       Impact factor: 9.097

Review 9.  Review 2: Primary graft dysfunction after lung transplant-pathophysiology, clinical considerations and therapeutic targets.

Authors:  Zhaosheng Jin; Ka Chun Suen; Zhiping Wang; Daqing Ma
Journal:  J Anesth       Date:  2020-07-20       Impact factor: 2.078

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.